neurocare integrates technology and science with the therapist, delivering evidence-based care with best-in-class efficacy.

neurocare is active in the fast-growing market for neurotherapy, ​​a non-invasive option for mental health, pain and rehabilitation using neuromodulation technologies integrated with psychotherapy. By measuring and modulating brain activity we help clinicians and patients to achieve significant and lasting therapeutic outcomes. We are further specialized in applying neuromodulation techniques (such as QEEG assessments) to improve diagnostics for choosing the right therapy (prognostics). This allows us to personalize treatment to the patient's needs.

neurocare offers treatment for psychiatric disorders, pain management and rehabilitation via its international network of neurocare clinics. At our neurocare academy we educate professionals, researchers and clinicians in the area of neuromodulation techniques supported by industry-leading technology.

neurcare’s technology brand neuroConn​ has long been a leader in EEG, neurostimulation and neurofeedback technology.  Its approach and implementation of slow cortical potentials (SCP) in the treatment of ADHD and epilepsy is considered the world standard in SCP-neurofeedback. Moreover, neuroConn is the leading technology brand in transcranial electric stimulation, co-determining the research in transcranial Direct Current Stimulation (tDCS), transcranial Alternating Current Stimulation (tACS) and transcranial Random Noise Stimulation (tRNS). In addition, its technology is commercially used in pain and rehabilitation management as an Original Equipment Manufacturer (OEM).

Our neurocare clinics offer specialized and integrated treatment with personalized solutions for ADHD, insomnia, depression and OCD. In these areas neurocare only employs state-of-the-art and evidence-based techniques, integrated and embedded in a clinical-psychological setting. Personalized neurofeedback is used in the treatment of ADHD, and brain stimulation (rTMS) for the treatment of depression using only evidence-based protocols.

These approaches are backed by over 15 years of scientific research implemented by Brainclinics and now offered by neurocare. The efficacy of our treatment is published in several peer-reviewed scientific publications.

For over 15 years the neurocare academy (formerly Brainclinics Education) has offered training courses for clinicians and researchers in the use of neuromodulation techniques in clinical practice and research, such as neurofeedback and rTMS. We have trained more than 1,000 professionals from over 30 different countries. Chances are a professional near you has received training from our academy in the past.